Endocrine Abstracts

Metabolic syndrome is an important social problem concerning a growing number of people. In different countries across Europe, its incidence is estimated at 17.4–28%. The metabolic syndrome is a constellation of risk factors for cardiovascular diseases. Hipothyreosis can additionally influence on lipid and carbohydrate disorders.

The described study was a prospective, two-centre (A. Jurasz University Hospital No. 1 in Bydgoszcz, District Hospital in Wabrzezno, Poland) screening study of 12-month duration. The study participants were 147 patients (120 women, 27 men, aged 28–95) with metabolic syndrome diagnosed according to the 2005 IDF.

The group was divided into two subgroups: with hipothyreosis (n=59) and with euthyreosis (n=88). We observed differences between the average level of triglycerides in control and study’ groups (161.46 vs 134.8 mg/dl; P=0.047). Also we noticed statistically significant differences between the average level of impaired fasting glucose in control and study’ groups (112.33 vs 126.07 mg/dl; P=0.044). There were no substantial differences in other parameters.

We suggest that patients with metabolic syndrome should have marked TSH and patients with hipothyreosis should be monitoring toward pronouncement of metabolic syndrome in the future.